Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

D

DBVT

DBV Technologies S.A.

NASDAQHealthcareBiotechnologyFR

NASDAQ · Healthcare · Biotechnology · FR

$13.47

−1.68%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Research · Sep 3, 2026

DBVT: FY25 Deep Dive

DBV Technologies FY25 at $0M. NI $-147M; EPS $-5.30.

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.